Bismuth oxyiodide-based composites for advanced visible-light activation of peroxymonosulfate in pharmaceutical mineralization

dc.contributor.author
Huidobro, Laura
dc.contributor.author
Domingo, Anna
dc.contributor.author
Gómez, Elvira
dc.contributor.author
Serrà i Ramos, Albert
dc.date.issued
2024-10-22T12:24:07Z
dc.date.issued
2024-10-22T12:24:07Z
dc.date.issued
2024-10-12
dc.date.issued
2024-10-22T12:24:07Z
dc.identifier
0045-6535
dc.identifier
https://hdl.handle.net/2445/215962
dc.identifier
751107
dc.description.abstract
The presence of pharmaceutical pollutants in water bodies represents a significant environmental and public health concern, largely due to their inherent persistence and potential to induce antibiotic resistance. Advanced oxidation processes (AOPs) that employ peroxymonosulfate (PMS) activation have emerged as an effective means of degrading these contaminants. Bismuth oxyiodides (BiOI), which are known for their visible-light photocatalytic properties, demonstrate considerable potential for removal of pharmaceutical pollutants. This study examines the synthesis and performance of BiOI-based composites with barium ferrite (BFO) nanoparticles for enhanced PMS activation under visible light. BiOI and Bi5O7I were synthesized via solvothermal and electrodeposition methods, respectively, and their morphologies and crystalline structures were observed to exhibit distinctive characteristics following annealing. The formation of the composite with BFO resulted in an improvement in the catalytic properties, which in turn enhanced the surface area and availability of active sites. The objective of the photocatalytic studies was to evaluate the degradation and mineralization of tetracycline (TC) under visible light, PMS, and combined conditions. The Bi5O7I(ED)-BFO catalyst was identified as the optimal candidate, achieving up to 99.8% TC degradation and 99.4% mineralization within 90 min at room temperature. The synergistic effect of BFO in BiOI-based composites significantly enhanced performance across all conditions, indicating their potential for efficient remediation of pharmaceutical pollutant. The material's performance was further evaluated in tap water, where the degradation efficiency decreased to 56.4% and mineralization to 38.2%. These results reflect the challenges posed by complex water matrices. However, doubling the PMS concentration to 5 mM led to improved outcomes, with 93.8% degradation and 81.4% mineralization achieved. These findings demonstrate the material's robust potential for treating pharmaceutical pollutants in real-world conditions, advancing sustainable water treatment technologies.
dc.format
14 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier Ltd
dc.relation
Reproducció del document publicat a: https://doi.org/https://doi.org/10.1016/j.chemosphere.2024.143532
dc.relation
Chemosphere, 2024, vol. 366, num.143532
dc.relation
https://doi.org/https://doi.org/10.1016/j.chemosphere.2024.143532
dc.rights
cc-by-nc-nd (c) Huidobro, Laura, et al., 2024
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciència dels Materials i Química Física)
dc.subject
Bismut
dc.subject
Contaminació de l'aigua
dc.subject
Bari
dc.subject
Bismuth
dc.subject
Water pollution
dc.subject
Barium
dc.title
Bismuth oxyiodide-based composites for advanced visible-light activation of peroxymonosulfate in pharmaceutical mineralization
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.